Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides

The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neuroendocrinology 2003-06, Vol.15 (6), p.564-571
Hauptverfasser: Jørgensen, H., Kjær, A., Knigge, U., Møller, M., Warberg, J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 571
container_issue 6
container_start_page 564
container_title Journal of neuroendocrinology
container_volume 15
creator Jørgensen, H.
Kjær, A.
Knigge, U.
Møller, M.
Warberg, J.
description The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of vasopressin and oxytocin in the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON). The 5‐HT precursor, 5‐hydroxytryptophan, injected in combination with the 5‐HT reuptake inhibitor, fluoxetine, increased oxytocin mRNA expression in the PVN, and the concentration of vasopressin and oxytocin in plasma, whereas mRNA in the SON was not affected. Intracerebroventricular infusion of 5‐HT agonists selective for the 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptor increased oxytocin mRNA in the SON and PVN. Infusion of agonists selective for the 5‐HT2A + 2C receptor increased vasopressin mRNA in the PVN, whereas none of the 5‐HT agonists affected vasopressin mRNA in the SON. All the 5‐HT agonists infused increased peripheral oxytocin concentration and vasopressin was increased by stimulation of the 5‐HT2A, 5‐HT2C and 5‐HT3 receptor. Intracerebroventricular infusion of 100 nmol 5‐HT increased the extracellular hypothalamic concentration of vasopressin as measured by microdialysis in the PVN. To evaluate the involvement of hypothalamic‐pituitary system in the 5‐hydroxytryptophan and fluoxetine‐induced vasopressin secretion, rats were immunoneutralized with a specific anti‐corticotropin‐releasing hormone antiserum. This treatment reduced plasma vasopressin and oxytocin responses. We conclude that stimulation with 5‐hydroxytryptophan or 5‐HT agonists increases mRNA expression of oxytocin in the PVN and the SON via stimulation of at least 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptors. Vasopressin mRNA in the PVN was increased only via the 5‐HT2 receptor, whereas vasopressin mRNA in the SON does not seem to be affected by 5‐HT stimulation. Corticotropin‐releasing hormone appears to be partly involved in the mediation of 5‐HT induced vasopressin and oxytocin secretion.
doi_str_mv 10.1046/j.1365-2826.2003.01032.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73223165</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>344600921</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5262-9598aeb1a5e49b069bb1f160ec58f27812dd009e2222a6520936a05ea8babefe3</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0EokvhLyALCW4J_oid-MChKsuWarVULQiJi3GSidZLEqd2Inb_PQ67aiVO-DKW5nlGo3cQwpSklGTy_S6lXIqEFUymjBCeEko4S_dP0OKh8RQtiBI8KajKztCLEHaE0Fxw8hydUZZTmZF8gX7egXej622P70bbTa0ZIeCrw-DGrWlNZyvc3W4u8HI_eAjBuh6bvsZrV5kW30ILJgB2Dd7A5N02asP2EGzs3cAw2hrCS_SsMW2AV6d6jr59Wn69vErWX1afLy_WSSWYZIkSqjBQUiMgUyWRqixpQyWBShQNywvK6poQBSw-IwUjiktDBJiiNCU0wM_Ru-Pcwbv7CcKoOxsqaFvTg5uCzjljnEoRwTf_gDs3-T7upqlSmYjRkAgVR6jyLgQPjR687Yw_aEr0fAK903PSek5azyfQf0-g91F9fZo_lR3Uj-Ip8wi8PQEmxBQbb_rKhkcuy1VWqJn7cOR-2xYO_72Avt4s51_0k6Nvwwj7B9_4X1rmPBf6-2als-ubYvXxB9OS_wGt_rDC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199452710</pqid></control><display><type>article</type><title>Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Jørgensen, H. ; Kjær, A. ; Knigge, U. ; Møller, M. ; Warberg, J.</creator><creatorcontrib>Jørgensen, H. ; Kjær, A. ; Knigge, U. ; Møller, M. ; Warberg, J.</creatorcontrib><description>The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of vasopressin and oxytocin in the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON). The 5‐HT precursor, 5‐hydroxytryptophan, injected in combination with the 5‐HT reuptake inhibitor, fluoxetine, increased oxytocin mRNA expression in the PVN, and the concentration of vasopressin and oxytocin in plasma, whereas mRNA in the SON was not affected. Intracerebroventricular infusion of 5‐HT agonists selective for the 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptor increased oxytocin mRNA in the SON and PVN. Infusion of agonists selective for the 5‐HT2A + 2C receptor increased vasopressin mRNA in the PVN, whereas none of the 5‐HT agonists affected vasopressin mRNA in the SON. All the 5‐HT agonists infused increased peripheral oxytocin concentration and vasopressin was increased by stimulation of the 5‐HT2A, 5‐HT2C and 5‐HT3 receptor. Intracerebroventricular infusion of 100 nmol 5‐HT increased the extracellular hypothalamic concentration of vasopressin as measured by microdialysis in the PVN. To evaluate the involvement of hypothalamic‐pituitary system in the 5‐hydroxytryptophan and fluoxetine‐induced vasopressin secretion, rats were immunoneutralized with a specific anti‐corticotropin‐releasing hormone antiserum. This treatment reduced plasma vasopressin and oxytocin responses. We conclude that stimulation with 5‐hydroxytryptophan or 5‐HT agonists increases mRNA expression of oxytocin in the PVN and the SON via stimulation of at least 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptors. Vasopressin mRNA in the PVN was increased only via the 5‐HT2 receptor, whereas vasopressin mRNA in the SON does not seem to be affected by 5‐HT stimulation. Corticotropin‐releasing hormone appears to be partly involved in the mediation of 5‐HT induced vasopressin and oxytocin secretion.</description><identifier>ISSN: 0953-8194</identifier><identifier>EISSN: 1365-2826</identifier><identifier>DOI: 10.1046/j.1365-2826.2003.01032.x</identifier><identifier>PMID: 12716407</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science, Ltd</publisher><subject>5-HT agonists ; 5-HT receptors ; Animals ; Biological and medical sciences ; Corticotropin-Releasing Hormone - metabolism ; Fluoxetine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation ; hypothalamus ; Male ; microdialysis ; mRNA ; mRNA expression ; oxytocin ; Oxytocin - biosynthesis ; Oxytocin - blood ; Oxytocin - secretion ; Paraventricular Hypothalamic Nucleus - drug effects ; Paraventricular Hypothalamic Nucleus - metabolism ; Paraventricular Hypothalamic Nucleus - secretion ; Rats ; Rats, Wistar ; Receptors, Serotonin - classification ; Receptors, Serotonin - drug effects ; Receptors, Serotonin - physiology ; RNA, Messenger ; serotonin ; Serotonin - physiology ; Serotonin Receptor Agonists - pharmacology ; Serotonin Uptake Inhibitors - pharmacology ; Supraoptic Nucleus - drug effects ; Supraoptic Nucleus - metabolism ; Supraoptic Nucleus - secretion ; vasopressin ; Vasopressins - biosynthesis ; Vasopressins - blood ; Vasopressins - secretion</subject><ispartof>Journal of neuroendocrinology, 2003-06, Vol.15 (6), p.564-571</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright Blackwell Scientific Publications Ltd. Jun 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5262-9598aeb1a5e49b069bb1f160ec58f27812dd009e2222a6520936a05ea8babefe3</citedby><cites>FETCH-LOGICAL-c5262-9598aeb1a5e49b069bb1f160ec58f27812dd009e2222a6520936a05ea8babefe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1365-2826.2003.01032.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1365-2826.2003.01032.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14794897$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12716407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jørgensen, H.</creatorcontrib><creatorcontrib>Kjær, A.</creatorcontrib><creatorcontrib>Knigge, U.</creatorcontrib><creatorcontrib>Møller, M.</creatorcontrib><creatorcontrib>Warberg, J.</creatorcontrib><title>Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides</title><title>Journal of neuroendocrinology</title><addtitle>J Neuroendocrinol</addtitle><description>The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of vasopressin and oxytocin in the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON). The 5‐HT precursor, 5‐hydroxytryptophan, injected in combination with the 5‐HT reuptake inhibitor, fluoxetine, increased oxytocin mRNA expression in the PVN, and the concentration of vasopressin and oxytocin in plasma, whereas mRNA in the SON was not affected. Intracerebroventricular infusion of 5‐HT agonists selective for the 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptor increased oxytocin mRNA in the SON and PVN. Infusion of agonists selective for the 5‐HT2A + 2C receptor increased vasopressin mRNA in the PVN, whereas none of the 5‐HT agonists affected vasopressin mRNA in the SON. All the 5‐HT agonists infused increased peripheral oxytocin concentration and vasopressin was increased by stimulation of the 5‐HT2A, 5‐HT2C and 5‐HT3 receptor. Intracerebroventricular infusion of 100 nmol 5‐HT increased the extracellular hypothalamic concentration of vasopressin as measured by microdialysis in the PVN. To evaluate the involvement of hypothalamic‐pituitary system in the 5‐hydroxytryptophan and fluoxetine‐induced vasopressin secretion, rats were immunoneutralized with a specific anti‐corticotropin‐releasing hormone antiserum. This treatment reduced plasma vasopressin and oxytocin responses. We conclude that stimulation with 5‐hydroxytryptophan or 5‐HT agonists increases mRNA expression of oxytocin in the PVN and the SON via stimulation of at least 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptors. Vasopressin mRNA in the PVN was increased only via the 5‐HT2 receptor, whereas vasopressin mRNA in the SON does not seem to be affected by 5‐HT stimulation. Corticotropin‐releasing hormone appears to be partly involved in the mediation of 5‐HT induced vasopressin and oxytocin secretion.</description><subject>5-HT agonists</subject><subject>5-HT receptors</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Corticotropin-Releasing Hormone - metabolism</subject><subject>Fluoxetine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation</subject><subject>hypothalamus</subject><subject>Male</subject><subject>microdialysis</subject><subject>mRNA</subject><subject>mRNA expression</subject><subject>oxytocin</subject><subject>Oxytocin - biosynthesis</subject><subject>Oxytocin - blood</subject><subject>Oxytocin - secretion</subject><subject>Paraventricular Hypothalamic Nucleus - drug effects</subject><subject>Paraventricular Hypothalamic Nucleus - metabolism</subject><subject>Paraventricular Hypothalamic Nucleus - secretion</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, Serotonin - classification</subject><subject>Receptors, Serotonin - drug effects</subject><subject>Receptors, Serotonin - physiology</subject><subject>RNA, Messenger</subject><subject>serotonin</subject><subject>Serotonin - physiology</subject><subject>Serotonin Receptor Agonists - pharmacology</subject><subject>Serotonin Uptake Inhibitors - pharmacology</subject><subject>Supraoptic Nucleus - drug effects</subject><subject>Supraoptic Nucleus - metabolism</subject><subject>Supraoptic Nucleus - secretion</subject><subject>vasopressin</subject><subject>Vasopressins - biosynthesis</subject><subject>Vasopressins - blood</subject><subject>Vasopressins - secretion</subject><issn>0953-8194</issn><issn>1365-2826</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1v1DAQhi0EokvhLyALCW4J_oid-MChKsuWarVULQiJi3GSidZLEqd2Inb_PQ67aiVO-DKW5nlGo3cQwpSklGTy_S6lXIqEFUymjBCeEko4S_dP0OKh8RQtiBI8KajKztCLEHaE0Fxw8hydUZZTmZF8gX7egXej622P70bbTa0ZIeCrw-DGrWlNZyvc3W4u8HI_eAjBuh6bvsZrV5kW30ILJgB2Dd7A5N02asP2EGzs3cAw2hrCS_SsMW2AV6d6jr59Wn69vErWX1afLy_WSSWYZIkSqjBQUiMgUyWRqixpQyWBShQNywvK6poQBSw-IwUjiktDBJiiNCU0wM_Ru-Pcwbv7CcKoOxsqaFvTg5uCzjljnEoRwTf_gDs3-T7upqlSmYjRkAgVR6jyLgQPjR687Yw_aEr0fAK903PSek5azyfQf0-g91F9fZo_lR3Uj-Ip8wi8PQEmxBQbb_rKhkcuy1VWqJn7cOR-2xYO_72Avt4s51_0k6Nvwwj7B9_4X1rmPBf6-2als-ubYvXxB9OS_wGt_rDC</recordid><startdate>200306</startdate><enddate>200306</enddate><creator>Jørgensen, H.</creator><creator>Kjær, A.</creator><creator>Knigge, U.</creator><creator>Møller, M.</creator><creator>Warberg, J.</creator><general>Blackwell Science, Ltd</general><general>Blackwell Science</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200306</creationdate><title>Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides</title><author>Jørgensen, H. ; Kjær, A. ; Knigge, U. ; Møller, M. ; Warberg, J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5262-9598aeb1a5e49b069bb1f160ec58f27812dd009e2222a6520936a05ea8babefe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>5-HT agonists</topic><topic>5-HT receptors</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Corticotropin-Releasing Hormone - metabolism</topic><topic>Fluoxetine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation</topic><topic>hypothalamus</topic><topic>Male</topic><topic>microdialysis</topic><topic>mRNA</topic><topic>mRNA expression</topic><topic>oxytocin</topic><topic>Oxytocin - biosynthesis</topic><topic>Oxytocin - blood</topic><topic>Oxytocin - secretion</topic><topic>Paraventricular Hypothalamic Nucleus - drug effects</topic><topic>Paraventricular Hypothalamic Nucleus - metabolism</topic><topic>Paraventricular Hypothalamic Nucleus - secretion</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, Serotonin - classification</topic><topic>Receptors, Serotonin - drug effects</topic><topic>Receptors, Serotonin - physiology</topic><topic>RNA, Messenger</topic><topic>serotonin</topic><topic>Serotonin - physiology</topic><topic>Serotonin Receptor Agonists - pharmacology</topic><topic>Serotonin Uptake Inhibitors - pharmacology</topic><topic>Supraoptic Nucleus - drug effects</topic><topic>Supraoptic Nucleus - metabolism</topic><topic>Supraoptic Nucleus - secretion</topic><topic>vasopressin</topic><topic>Vasopressins - biosynthesis</topic><topic>Vasopressins - blood</topic><topic>Vasopressins - secretion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jørgensen, H.</creatorcontrib><creatorcontrib>Kjær, A.</creatorcontrib><creatorcontrib>Knigge, U.</creatorcontrib><creatorcontrib>Møller, M.</creatorcontrib><creatorcontrib>Warberg, J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroendocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jørgensen, H.</au><au>Kjær, A.</au><au>Knigge, U.</au><au>Møller, M.</au><au>Warberg, J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides</atitle><jtitle>Journal of neuroendocrinology</jtitle><addtitle>J Neuroendocrinol</addtitle><date>2003-06</date><risdate>2003</risdate><volume>15</volume><issue>6</issue><spage>564</spage><epage>571</epage><pages>564-571</pages><issn>0953-8194</issn><eissn>1365-2826</eissn><abstract>The neurotransmitter serotonin (5‐HT) stimulates the secretion of vasopressin and oxytocin, and 5‐HT is involved in the mediation of the vasopressin and oxytocin response to stress. In male Wistar rats, we investigated the 5‐HT receptors involved in the 5‐HT‐induced increase of mRNA expression of vasopressin and oxytocin in the hypothalamic paraventricular nucleus (PVN) and supraoptic nucleus (SON). The 5‐HT precursor, 5‐hydroxytryptophan, injected in combination with the 5‐HT reuptake inhibitor, fluoxetine, increased oxytocin mRNA expression in the PVN, and the concentration of vasopressin and oxytocin in plasma, whereas mRNA in the SON was not affected. Intracerebroventricular infusion of 5‐HT agonists selective for the 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptor increased oxytocin mRNA in the SON and PVN. Infusion of agonists selective for the 5‐HT2A + 2C receptor increased vasopressin mRNA in the PVN, whereas none of the 5‐HT agonists affected vasopressin mRNA in the SON. All the 5‐HT agonists infused increased peripheral oxytocin concentration and vasopressin was increased by stimulation of the 5‐HT2A, 5‐HT2C and 5‐HT3 receptor. Intracerebroventricular infusion of 100 nmol 5‐HT increased the extracellular hypothalamic concentration of vasopressin as measured by microdialysis in the PVN. To evaluate the involvement of hypothalamic‐pituitary system in the 5‐hydroxytryptophan and fluoxetine‐induced vasopressin secretion, rats were immunoneutralized with a specific anti‐corticotropin‐releasing hormone antiserum. This treatment reduced plasma vasopressin and oxytocin responses. We conclude that stimulation with 5‐hydroxytryptophan or 5‐HT agonists increases mRNA expression of oxytocin in the PVN and the SON via stimulation of at least 5‐HT1A, 5‐HT1B, 5‐HT2A and 5‐HT2C receptors. Vasopressin mRNA in the PVN was increased only via the 5‐HT2 receptor, whereas vasopressin mRNA in the SON does not seem to be affected by 5‐HT stimulation. Corticotropin‐releasing hormone appears to be partly involved in the mediation of 5‐HT induced vasopressin and oxytocin secretion.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science, Ltd</pub><pmid>12716407</pmid><doi>10.1046/j.1365-2826.2003.01032.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0953-8194
ispartof Journal of neuroendocrinology, 2003-06, Vol.15 (6), p.564-571
issn 0953-8194
1365-2826
language eng
recordid cdi_proquest_miscellaneous_73223165
source MEDLINE; Access via Wiley Online Library
subjects 5-HT agonists
5-HT receptors
Animals
Biological and medical sciences
Corticotropin-Releasing Hormone - metabolism
Fluoxetine - pharmacology
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation
hypothalamus
Male
microdialysis
mRNA
mRNA expression
oxytocin
Oxytocin - biosynthesis
Oxytocin - blood
Oxytocin - secretion
Paraventricular Hypothalamic Nucleus - drug effects
Paraventricular Hypothalamic Nucleus - metabolism
Paraventricular Hypothalamic Nucleus - secretion
Rats
Rats, Wistar
Receptors, Serotonin - classification
Receptors, Serotonin - drug effects
Receptors, Serotonin - physiology
RNA, Messenger
serotonin
Serotonin - physiology
Serotonin Receptor Agonists - pharmacology
Serotonin Uptake Inhibitors - pharmacology
Supraoptic Nucleus - drug effects
Supraoptic Nucleus - metabolism
Supraoptic Nucleus - secretion
vasopressin
Vasopressins - biosynthesis
Vasopressins - blood
Vasopressins - secretion
title Serotonin Stimulates Hypothalamic mRNA Expression and Local Release of Neurohypophysial Peptides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T11%3A24%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Serotonin%20Stimulates%20Hypothalamic%20mRNA%20Expression%20and%20Local%20Release%20of%20Neurohypophysial%20Peptides&rft.jtitle=Journal%20of%20neuroendocrinology&rft.au=J%C3%B8rgensen,%20H.&rft.date=2003-06&rft.volume=15&rft.issue=6&rft.spage=564&rft.epage=571&rft.pages=564-571&rft.issn=0953-8194&rft.eissn=1365-2826&rft_id=info:doi/10.1046/j.1365-2826.2003.01032.x&rft_dat=%3Cproquest_cross%3E344600921%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=199452710&rft_id=info:pmid/12716407&rfr_iscdi=true